Prebiotics and Probiotics in Infant Nutrition

Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion

Volumn , Issue , 2016, Pages 101-134

  Zuppa, Antonio Alberto ^a   Alighieri, Giovanni ^a   Scorrano, Antonio ^b   Catenazzi, Piero ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Cardinale G Panico Hospital   (Italy)

Author keywords

Functional foods; Gut microbiota; Human milk; Microbial epithelial cross talk; Nondigestible oligosaccharides; Prebiotics; Probiotics; Symbiotics

Indexed keywords

EID: 84966874224     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802189-7.00008-3     Document Type: Chapter

References (389)

1. Abrahamsson T.R., Jakobsson T., Bottcher M.F., Fredrikson M., Jenmalm M.C., Bjorkstén B., Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119:1174-1180.
2. Agarwal R., Sharma N., Chaudhry R., Deorari A., Paul V.K., Gewolb I.H., Panigrahi P. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J. Pediatr. Gastroenterol. Nutr. 2003, 36:397-402.
3. Agostoni C., Axelsson I., Braegger C., Goulet O., Koletzko B., Michaelsen K.F., Rigo J., Shamir R., Szajewska H., Turck D., Weaver L.T. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2004, 38:365-374. ESPGHAN Committee on Nutrition.
4. Agostoni C., Axelsson I., Goulet O., Koletzko B., Michaelsen K.F., Puntis J.W., Rigo J., Shamir R., Szajewska H., Turck D. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2004, 39(5):465-473. ESPGHAN Committee on Nutrition.
5. Aires J., Doucet-Populaire F., Butel M.J. Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans. Appl. Environ. Microbiol. 2007, 73(8):2751-2754.
6. Albers R., Antoine J.M., Bourdet-Sicard R., Calder P.C., Gleeson M., Lesourd B., Samartín S., Sanderson I.R., Van Loo J., Vas Dias F.W., Watzl B. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 2005, 94(3):452-481.
7. Allen S.J., Okoko B., Martinez E., Gregorio G., Dans L.F. Probiotics for treating infectious diarrhoea. Cochrane Database Syst. Rev. 2004, 2:CD003048.
8. Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010, 10(11):CD003048.
9. Alles M.S. Consumption of fructooligosaccharides does not favourably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am. J. Clin. Nutr. 1999, 69:64-69.
10. Alliet P., Scholtens P., Raes M., Vandenplas Y., Kroes H., Knol J. An infant formula containing a specific prebiotic mixture of GOS/lc FOS leads to higher faecal secretory IgA in infants. J. Pediatr. Gastroenterol. Nutr. 2007, 44(Suppl. 1):179.
11. Almansa C., Agrawal A., Houghton L.A. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome. Expert Rev. Gastroenterol. Hepatol. 2012, 6:383-398.
12. Anderson G.G., Palermo J.J., Schilling J.D., Roth R., Heuser J., Hultgren S.J. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003, 301:105-107.
13. Arshad S.H., Bateman B., Sadeghnejad A., Gant C., Matthews S.M. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J. Allergy Clin. Immunol. 2007, 119:307-313.
14. Arslanoglu S., Moro G., Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J. Nutr. 2007, 137:2420-2424.
15. Arslanoglu S., Moro G., Schmitt J., Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the allergy associated symptoms and infections during the first 2 years of life. J. Pediatr. Gastroenterol. Nutr. 2007, 40(Suppl. 1):129.
16. Arslanoglu S., Moro G.E., Schmitt J., Tandoi L., Rizzardi S., Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 2008, 138:1091-1095.
17. Arvola T., Moilanen E., Vuento R., Isolauri E. Weaning to hypoallergenic formulas improves gut barrier during weaning in atopic infants. J. Pediatr. Gastroenterol. Nutr. 2004, 38(1):92-96.
18. Bakker-Zierikzee A.M., Alles M., Knol J., Kok F.J., Tolboom J.J.M., Bindels J.G. Effects of infant formula containing a mixture of galacto and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br. J. Nutr. 2005, 94:783-790.
19. Bakker-Zierikzee A.M., Tol E.A., Kroes H., Alles M.S., Kok F.J., Bindels J.G. Faecal sIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr. Allergy Immunol. 2006, 17:134-140.
20. Balmer S.E., Wharton B.A. Diet and faecal flora in the newborn: breast milk and infant formula. Arch. Dis. Child. 1989, 64:1672-1677.
21. Balsari A., Ceccarelli A., Dubini F. The faecal bacterial population in the irritable bowel syndrome. Microbiologica 1982, 5:185-194.
22. Banaszkiewicz A., Szajewska H. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J. Pediatr. 2005, 146:364-369.
23. Barcenilla A., Pryde S.E., Martin J.C., Duncan S.H., Stewart C.S., Henderson C., Flint H.J. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 2000, 66:1654-1661.
24. Barclay A.R., Stenson B., Simpson J.H., Weaver L.T., Wilson D.C. Probiotics for necrotizing enterocolitis: a systematic review. J. Pediatr. Gastroenterol. Nutr. 2007, 45(Suppl. 5):569-576.
25. Bausserman M., Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J. Pediatr. 2005, 147(2):197-200.
26. Beachey E.H. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J. Infect. Dis. 1981, 143:325.
27. Becquet P. EU assessment of enterococci as feed additives. Int. J. Food Microbiol. 2003, 88:247-254.
28. Ben X., Zhou X., Zhao W., Yu W., Pan W., Zhang W., Wu S.M., Van Beusekom C.M., Schaafsma A. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin. Med. J. 2004, 117:927-931.
29. Bennet R., Eriksson M., Nord C.E., Zetterstrom R. Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr. Infect. Dis. 1986, 5:533-539.
30. Benno Y., Sawada K., Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol. Immunol. 1984, 28:975-986.
31. Berg R.D. Probiotics, prebiotics or conbiotics?. Trends Microbiol. 1998, 6:89-92.
32. Bernardo W.M., Aires F.T., Carneiro R.M., Sá F.P., Rullo V.E., Burns D.A. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J. Pediatr. (Rio J) 2013, 89(1):18-24.
33. Bernet M.F., Brassart D., Nesser J.R., Servin A.I. Lactobacillus acidophilus LA1 binds to human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994, 35:483-489.
34. Bettler J., Euler A.R. An evaluation of the growth of term infants fed formula supplemented with fructo-oligosaccharides. Int. J. Probiotics Prebiotics 2006, 1:19-26.
35. Bin-Nun A., Bromiker R., Wilschanski M., Kaplan M., Rudensky B., Caplan M., Hammerman C. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 2005, 147(Suppl. 2):192-196.
36. Bjorksten B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and intestinal flora during the first year of life. J. Allergy Clin. Immunol. 2001, 108:516-520.
37. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J. Nutr. 2006, 136:2127-2130.
38. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., Marini A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 2002, 86:178-181.
39. Boehm G., Fanaro S., Jelinek J., Stahl B., Marini A. Prebiotic concept for infant nutrition. Acta Paediatr. (Suppl.) 2003, 91:64-67.
40. Bongers M.E.J., de Lorijn F., Reitsma J.B., Groeneweg M., Taminiau J.A.J.M., Benninga M.A. The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized crossover trial. Nutr. J. 2007, 6:8-15.
41. Borruel N., Carol M., Casellas F., Antolín M., de Lara F., Espín E., Naval J., Guarner F., Malagelada J.R. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be do downregulated ex vivo by probiotic bacteria. Gut 2002, 51(5):659-664.
42. Bousvaros A., Guandalini S., Baldassano R.N., Botelho C., Evans J., Ferry G.D., Goldin B., Hartigan L., Kugathasan S., Levy J., Murray K.F., Oliva-Hemker M., Rosh J.R., Tolia V., Zholudev A., Vanderhoof J.A., Hibberd P.L. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm. Bowel Dis. 2005, 11(9):833-839.
43. Boyle R.J., Robins-Browne R.M., Tang M.L. Probiotic use in clinical practice: what are the risks?. Am. J. Clin. Nutr. 2006, 83(6):1256-1264.
44. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., Murrell D.F., Tang M.L. Probiotics for treating eczema. Cochrane Database Syst. Revx. 2008, 4:CD006135.
45. Bruce A.W., Chadwick P., Hassan A., VanCott G.F. Recurrent urethritis in women. Can. Med. Assoc. J. 1973, 108:973-976.
46. Bruckschen E., Horosiewicz H. Chronische Obstipation. Vergleich von mikrobiologischer Therapie und Laktulose. Munch. Med. Wochenschr. 1994, 16:241-245.
47. Brunser O., Gotteland M., Cruchet S., Figueroa G., Garrido D., Steenhout P. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr. Res. 2006, 59:451-456.
48. Bruzzese E., Volpicelli M., Salvini F., Bisceglia M., Lionetti P., Chinquetti M., Iacono G., Guarino A. Early administration of GOS/FOS prevents intestinal and respiratory infections in infants. J. Pediatr. Gastroenterol. Nutr. 2006, 42:95.
49. Bu L.N., Chang M.H., Ni Y.H., Chen H.L., Cheng C.C. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr. Int. 2007, 49(4):485-490.
50. Butel M.J. Probiotics, gut microbiota and health. Med. Mal. Infect. 2014, 44(1):1-8.
51. Butel M.J., Suau A., Campeotto F., Magne F., Aires J., Ferraris L., Kalach N., Leroux B., Dupont C. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J. Pediatr. Gastroenterol. Nutr. 2007, 44:577-582.
52. Butterworth A.D., Thomas A.G., Akobeng A.K. Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 2008, CD006634.
53. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N. Engl. J. Med. 2012, 367:1626-1635.
54. Campieri M., Rizzello F., Venturi A. Combination of antibiotic and prebiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease. Gastroenterology 2000, 118:781.
55. Cannon J.P., Lee T.A., Bolanos J.T., Danziger L.H. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24(1):31-40.
56. Caplan M.S., Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J. Pediatr. Gastroenterol. Nutr. 2000, 30:S18-S22.
57. Carabin I.G., Flamm W.G. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul. Toxicol. Pharmacol. 1999, 30(Suppl. 3):268-282.
58. Carvalho R.S., Michail S., Ashai-Khan F., Mezoff A.G. An update on pediatric gastroenterology and nutrition: a review of some recent advances. Curr. Probl. Pediatr. Adolesc. Health Care 2008, 38:204-228.
59. Charrois T., Sandhu G., Vohra S. Probiotics. Pediatr. Rev. 2006, 27:4.
60. Chaturvedi P., Warren C.D., Altaye M., Morrow A.L., Ruiz-Palacios G., Pickering L.K., Newburg D.S. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001, 11:365-372.
61. Chitkara D.K., Montgomery R.K., Grand R.J., Büller H.A. Lactose intolerance. UpToDate 2007, UpToDate, Waltham, MA. B.D. Rose (Ed.).
62. Chouraqui J.P., Van Egroo L.D., Fichot M.C. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J. Pediatr. Gastroenterol. Nutr. 2004, 38:288-292.
63. Chouraqui J.P., Dupont C., Bocquet A., Bresson J.L., Briend A., Darmaun D., Frelut M.L., Ghisolfi J., Girardet J.P., Goulet O., Putet G., Rieu D., Rigo J., Turck D., Vidailhet M. Alimentation des premiers mois de vie et prévention de l'allergie. Arch. Pediatr. 2008, 15:431-442.
64. Chouraqui J.P., Grathwohl D., Labaune J.M., Hascoet J.M., de Montgolfier I., Leclaire M., Giarre M., Steenhout P. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am. J. Clin. Nutr. 2008, 87:1365-1373.
65. Claud E.C., Walker W.A. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J. 2001, 15:1398-1403.
66. Collins M.D., Gibson G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 1999, 69:1052-1057.
67. Committee on Nutrition, American Academy of Pediatrics Hypoallergenic infant formulas. Pediatrics 2002, 106:346-349.
68. Connolly E., Abrahamsson T., Björkstén B. Safety of D(-)-lactic acid producing bacteria in the human infant. J. Pediatr. Gastroenterol. Nutr. 2005, 41(4):489-492.
69. Conseil de l'Europe, 2001-4. Lignes directrices sur la justification scientifique des allégations santé des aliments functionnels. Document technique . http://www.coe.fr/%20soc-sp%20Arch/dav.
70. Conway P. Development of intestinal microbial. Gastrointestinal Microbiology 1997, vol. 2:3-38. R.I. Mackie (Ed.).
71. Coppa G.V., Pierani P., Zampini L., Bruni S., Carloni I., Gabrielli O. Characterization of oligosaccharides in milk and feces of breast-fed infants by high performance anion exchange chromatography. Adv. Exp. Med. Biol. 2001, 501:307-314.
72. Correa N.B., Peret Filho L.A., Penna F.J., Lima F.M., Nicoli J.R. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J. Clin. Gastroenterol. 2005, 39:385-389.
73. Costalos C., Kapiki A., Apostolou M., Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum. Dev. 2008, 84:45-49.
74. Costa-Ribeiro H., Ribeiro T.C., Mattos A.P., Valois S.S., Neri D.A., Almeida P., Cerqueira C.M., Ramos E., Young R.J., Vanderhoof J.A. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J. Pediatr. Gastroenterol. Nutr. 2003, 36:112-115.
75. Cremonini F., Di Caro S., Covino M., Armuzzi A., Gabrielli M., Santarelli L., Nista E.C., Cammaroa G., Gasbarrini G., Gasbarrini A. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel-group, triple-blind, placebo-controlled study. Am. J. Gastroenterol. 2002, 97:2744-2749.
76. Cremonini F., Di Caro S., Nista E.C., Bartolozzi F., Capelli G., Gasbarrini G., Gasbarrini A. Meta-analysis: the effect of prebiotic administration on antibiotic-associated diarrhea. Aliment. Pharmacol. Ther. 2002, 16(8):1461-1467.
77. Cucchiara S., Falconieri P., Di Nardo G., Parcelii M.A., Dito L., Grandinetti A. New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in pediatric age. Dig. Liver Dis. 2002, 34(Suppl. 2):44-47.
78. Cummings J.H. Short chain fatty acids in the human colon. Gut 1981, 22:763-779.
79. Cummings J.H., Gibson G.R., Macfarlane G.T. Quantitative estimates of fermentation in the hind gut of man. Acta Vet. Scand. 1989, 86:76-82.
80. Cuthbertson W.J.F. Evolution of infant nutrition. Br. J. Nutr. 1999, 81:359-371.
81. Dani C., Biadaioli R., Bertini G., Martelli E., Rubaltelli F.F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective double-blind study. Biol. Neonate 2002, 82:103-108.
82. Davidson M.H. Evaluation of the influence of dietary inulin on serum lipids in adults with hypercholesterolemia. Nutr. Res. 1998, 18:503-517.
83. De Bruyn A., Alvarez A.P., Sandra P., De Leenheer L. Isolation and identification of O-beta-D-fructofuranosyl-(2->1)-O-beta-D-fructofuranosyl-(2->1)-D-fructose, a product of the enzymic hydrolysis of the inulin from Cichorium intybus. Carbohydr. Res. 1992, 235:303-308.
84. de Vrese M., Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 2008, 111:1-66.
85. de Vrese M., Stegelmann A., Richter B., Fenselau S., Laue C., Schrezenmeir J. Probiotics-compensation for lactose insufficiency. Am. J. Clin. Nutr. 2001, 73(Suppl. 2):421-429.
86. Decsi T., Arato A., Balogh M., Dolinary T., Kanjo A.H., Szabo E., Várkonyi A. Randomized placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy term infants (translation from Hungarian language). Orv. Hetil. 2005, 146:2445-2450.
87. Deplancke B., Gaskins H.R. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 2001, 73:1131-1141.
88. Deshpande G., Rao S., Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007, 369:1614-1620.
89. Donnet-Hughes A., Rochat F., Serrant P., Aeschlimann J.M., Schiffrin E.J. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J. Dairy Sci. 1999, 82:863-869.
90. Duggan C., Penny M.E., Hibberd P., Gil A., Huapaya A., Cooper A., Coletta F., Emenhiser C., Kleinman R.E. Oligofructose supplemented infant cereal: 2 randomised, blinded, community-based trials in Peruvian infants. Am. J. Clin. Nutr. 2003, 77:937-942.
91. Dunlop S.P., Jenkins D., Neal K.R., Spiller R.C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003, 125:1651-1659.
92. Egervärn M., Roos S., Lindmark H. Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum. J. Appl. Microbiol. 2009, 107(5):1658-1668.
93. Elson C.O., Mestecky J.F. The mucosal immune system. Infections of the Gastrointestinal Tract 1995, 153-162. Raven Press Ltd, New York. M.J. Blaser, P.D. Smith, J.I. Ravdin, H.B. Greenberg, R.L. Guerrant (Eds.).
94. Engfer M.B., Stahl B., Finke B., Sawatzki G., Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am. J. Clin. Nutr. 2000, 71:1589-1596.
95. Erickson K.L., Hubbard N.E. Probiotic immunomodulation in health and disease. J. Nutr. 2000, 130:403-409.
96. Escher J.C., de Koning N.D., van Engen C.G. Molecular basis of lactase levels in adult humans. J. Clin. Invest. 1992, 89:480-483.
97. Euler A.R., Mitchell D.K., Kline R., Pickering L.K. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. J. Pediatr. Gastroenterol. Nutr. 2005, 40:157-164.
98. Faber S.M. Comparison of probiotics and antibiotics to probiotics alone in treatment of diarrhea predominant IBS (D-IBS), alternating (A-IBS) and constipation (C-IBS) patients. Gastroenterology 2000, 118:687-688.
99. Fajardo O., Naim H.Y., Lacey S.W. The polymorphic expression of lactase in adults is regulated at the messenger RNA level. Gastroenterology 1994, 106:1233-1241.
100. Falk P.G., Hooper L.V., Mittvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 1998, 62:1157-1170.
101. Fanaro S., Chierici R., Guerrini P., Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr. (Suppl.) 2003, 91:48-55.
102. Fanaro S., Jelinek J., Stahl B., Boehm G., Kock R., Vigi V. Acidic oligosaccharides from pectin hydrosylate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J. Pediatr. Gastroenterol. Nutr. 2005, 41:186-190.
103. FAO, WHO, 2001. The Food and Agriculture Organization of the United Nations and the World Health Organization Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO Report No. 10-1-2001.
104. Favier C.F., Vaughan E.E., De Vos W.M., Akkermans A.D. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 2002, 68:219-226.
105. Fell J.M. Neonatal inflammatory intestinal diseases: necrotizing enterocolitis and allergic colitis. Early Hum. Dev. 2005, 81:117-122.
106. Fernandez-Banares F. Nutritional care of the patient with constipation. Best Pract. Res. Clin. Gastroenterol. 2006, 20:575-587.
107. Firmansyah A., Pramita G.D., Fassler Carrie A.L., Hascke F., Link-Amster H. Improved humoral immune response to measles vaccine in infants receiving cereal with fructooligosaccharides. J. Pediatr. Gastroenterol. Nutr. 2000, 31(2):134.
108. Fontana M., Martelli L. Probiotics in paediatric gastroenterology: evidenze cliniche. Medico e Bambino 2004, 23:175-182.
109. Frank A. Technological functionally of inulin and oligofructose. Br. J. Nutr. 2002, 87:287-291.
110. Franz C.M., Huch M., Abriouel H., Holzapfel W., Gálvez A. Enterococci as probiotics and their implications in food safety. Int. J. Food Microbiol. 2011, 151(2):125-140.
111. Fujii T., Ohtsuka Y., Lee T., Kudo T., Shoji H., Sato H., Nagata S., Shimizu T., Yamashiro Y. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2006, 43(1):83-88.
112. Gaón D., García H., Winter L., Rodríguez N., Quintás R., González S.N., Oliver G. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B. Aires) 2003, 63(4):293-298.
113. Garofalo R.P., Goldman A.S. Expression of functional immunomodulatory and anti-inflammatory factors in human milk. Clin. Perinatol. 1999, 26:361-377.
114. Gibson G.R. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995, 125:1401-1412.
115. Gibson G.R., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 1994, 77(Suppl. 4):412-420.
116. Gibson G.R., Berry-Ottaway P., Rastall R.A. Probiotics: New Developments in Functional Foods 2000, Chandos Publishing Ltd, Oxford.
117. Gibson G.R., Probert H.M., Van Loo J.A.E., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17:259-275.
118. Gilliland S.E. Influence of bacterial starter cultures on nutritional value of foods: improvement of lactose digestion by consuming foods containing lactobacilli. CDP 1985, 20:28-33.
119. Gionchetti P., Amadini C., Rizzello F., Venturi A., Palmonari V., Morselli C., Romagnoli R., Campieri M. Probiotics-role in inflammatory bowel disease. Dig. Liver Dis. 2002, 34(Suppl. 2):58-62.
120. Gionchetti P., Morselli C., Rizzello F., Romagnoli R., Campieri M., Poggioli G., Laureti S., Ugolini F., Pierangeli F. Management of pouch dysfunction or pouchitis with an ileoanal pouch. Best Pract. Res. Clin. Gastroenterol. 2004, 18:993-1006.
121. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., Vitali B., Poggioli G., Miglioli M., Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202-1209.
122. Gionchetti P., Rizzello F., Lammers K.M., Morselli C., Sollazzi L., Davies S., Tambasco R., Calabrese C., Campieri M. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J. Gastroenterol. 2006, 12(21):3306-3313.
123. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli M., Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305-309.
124. Giorgi P.L. Gli alimenti funzionali. Bambini e nutrizione 2002, 9(2):57-58.
125. Gluck U., Gebbers J.O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am. J. Clin. Nutr. 2003, 77:517-520.
126. Gnoth M.J., Kunz C., Kinne-Safrane E., Rudloff S. Human milk oligosaccharides are minimally digested in vitro. J. Nutr. 2000, 130:3014-3020.
127. Goldenberg J.Z., Ma S.S., Saxton J.D., Martzen M.R., Vandvik P.O., Thorlund K., Guyatt G.H., Johnston B.C. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev. 2013, 5:CD006095.
128. Goldman A.S., Cheda S., Garofalo R. Spectrum of immunomodulating agents in human milk. IJPHO 1997, 4:491-497.
129. Gorbach S.L. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 2000, 95:2-4.
130. Gorbach S.L., Chang T.W., Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987, 2:15-19.
131. Grand R.J., Montgomery R.K. Lactose malabsorption. Curr. Treat. Options Gastroenterol. 2008, 11:19-25.
132. Grizard D. Non digestible oligosaccharides used as prebiotic agents: mode of production and beneficial effects on animal and human health. Reprod. Nutr. Dev. 1999, 39:563-588.
133. Guandalini S. Use of Lactobacillus GG in pediatric Crohn's disease. Dig. Liver Dis. 2002, 34:63-65.
134. Guandalini S., Pensabene L., Zikri M.A. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 2000, 30:54-60.
135. Guarino A., Bruzzese E. I probiotici: indicazioni cliniche certe e potenziali meccanismi d'azione. Prospettive Pediatria 2001, 31:309-320.
136. Guarino A., Canai R.B., Spagnolo M.I., Albano F., Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 1997, 25:516-519.
137. Guarino A., Ashkenazi S., Gendrel D., Lo Vecchio A., Shamir R., Szajewska H. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J. Pediatr. Gastroenterol. Nutr. 2014, 59(1):132-152.
138. Guarner F., Schaafsma G.J. Probiotics. Int. J. Food Microbiol. 1998, 39:237-238.
139. Gupta P., Andrew H., Kirschner B.S., Guandalini S. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 2000, 31(4):53-57.
140. Gutierrez C., Marco A., Nogales A., Tebar R. Total and segmental colonic transit time and anorectal manometry in children with chronic idiopathic constipation. J. Pediatr. Gastroenterol. Nutr. 2002, 35:31-38.
141. Gwee K.A., Leong Y.L., Graham C., McKendrick M.W., Collins S.M., Walters S.J., Underwood J.E., Read N.W. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999, 44(3):400-406.
142. Gwee K.A., Collins S.M., Read N.W., Rajnakova A., Deng Y., Graham J.C., McKendrick M.W., Moochhala S.M. Increased rectal mucosal expression of interleukin 1 beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52(4):523-526.
143. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 2005, 71:2318-2324.
144. Halken S., Hansen K.S., Jacobsen H.P., Estmann A., Faelling A.E., Hansen L.G., Kier S.R., Lassen K., Lintrup M., Mortensen S., Ibsen K.K., Osterballe O., Høst A. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr. Allergy Immunol. 2000, 11(3):149-161.
145. Halpern G.M., Prindville T., Blankenburg M., Hsia T., Gershwin M.E. Treatment of irritable bowel syndrome with Lacteol forte: a randomized, double-blind, cross-over trial. Am. J. Gastroenterol. 1996, 91:1579-1585.
146. Hamosh M. Breastfeeding. Unravelling the mysteries of mother's milk. Medscape Womens Health 1996, 16:4-9.
147. Harmsen H.J., Wildeboer-Veloo A.C., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J., Welling G.W. Analysis of intestinal flora development in breast fed and formula fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000, 30:61-67.
148. Harmsen H.J.M., Wildeboer-Veloo A.C.M., Grijpstra J., Knol J., Degener J.E., Welling G.W. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human faeces from volunteers of different age groups. Appl. Environ. Microbiol. 2000, 66:4523-4527.
149. Hart A.L., Stagg A.J., Kamm M.A. Use of probiotics in the treatment of inflammatory bowel disease. J. Clin. Gastroenterol. 2003, 36:111-119.
150. Hatakka K., Savilahti E., Ponka A. Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomised trial. Br. Med. J. 2001, 322:1327-1331.
151. Hill M.J. Bacterial fermentation of complex carbohydrate in the human colon. Eur. J. Cancer Prev. 1995, 4:353-358.
152. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., Calder P.C., Sanders M.E. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11:506-514.
153. Holman R.C., Stehr-Green J.K., Zelasky M.T. Necrotizing enterocolitis mortality in the United States, 1979-85. Am. J. Public Health 1989, 79:987-989.
154. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
155. Hopkins M.J., Macfarlane G.T., Furrie E. Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridization analyses. FEMS Microbiol. Ecol. 2005, 54:77-85.
156. Høst A., Koletzko B., Dreborg S., Muraro A., Wahn U., Aggett P., Bresson J.L., Hernell O., Lafeber H., Michaelsen K.F., Micheli J.L., Rigo J., Weaver L., Heymans H., Strobel S., Vandenplas Y. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch. Dis. Child. 1999, 81:80-84.
157. Hoveyda N., Heneghan C., Mahtani K.R., Perera R., Roberts N., Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009, 9:15.
158. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Infect. Dis. 1999, 3:197-202.
159. Huurre A., Laitinen K., Rautava S., Korkeamakiz M., Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin. Exp. Allergy 2008, 38:1342-1348.
160. Indrio F., Riezzo G., Montagna O., Valenzano E., Mautone A., Boehm G. Effect of a prebiotic mixture of short chain galacto-oligosaccharides and long chain fructo-oligosaccharides on gastric motility in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2007, 44(Suppl. 1):217.
161. Isolauri E. Probiotics in human disease. Am. J. Clin. Nutr. 2001, 73:1142-1146.
162. Isolauri E. The role of probiotics in paediatrics. Curr. Paediatr. 2004, 14:104-109.
163. Isolauri E., Arvola T., Sutas Y., Moilanen E., Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000, 30:1604-1610.
164. Jacobsen L., Wilcks A., Hammer K., Huys G., Gevers D., Andersen S.R. Horizontal transfer of tet(M) and erm(B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastrointestinal tract of gnotobiotic rats. FEMS Microbiol. Ecol. 2007, 59(1):158-166.
165. Jeurink P.V., Van Esch B.C., Rijnierse A., Garssen J., Knippels L.M. Mechanisms underlying immune effects of dietary oligosaccharides. Am. J. Clin. Nutr. 2013, 98(2):572S-577S.
166. Jose M., Saavedra M.D. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr. Clin. Pract. 2007, 22:351-365.
167. Kaila M., Isolauri E., Soppi E., Virtanen E., Laine S., Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 1992, 32:141-144.
168. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001, 357:1076-1079.
169. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871.
170. Kanauchi O., Mitsuyama K., Arabki Y., Andoh A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm. Des. 2003, 9:333-346.
171. Kapiki A., Costalos C., Oikonomidou C., Triantafylldou A., Loukatou E., Pertrohilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum. Dev. 2007, 83:335-339.
172. Kassinen A., Krogius-Kurikka L., Mäkivuokko H., Rinttilä T., Paulin L., Corander J., Malinen E., Apajalahti J., Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133(1):24-33.
173. Kennedy R.J., Kirk S.J., Gardiner K.R. Mucosal barrier function and the commensal flora. Gut 2002, 50:441-442.
174. Kim H.J., Camilleri M., Mc Kinzie S., Lempke M.B., Burton D.D., Thomforde G.M., Zinsmeister A.R. A randomized controlled trial of a probiotic, VSL 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003, 17:895-904.
175. Kim S.H., Lee D.H., Meyer D. Supplementation of infant formula with native inulin has a prebiotic effect in formula-fed babies. Asia Pac. J. Clin. Nutr. 2007, 16:172-177.
176. King T.S., Elia M., Hunter J.O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998, 352:1187-1189.
177. Kirjavainen P.V., Salminen S.J., Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 2003, 36:223-227.
178. Kleesen B., Kroesen A.J., Buhr H.J., Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 2002, 37:1034-1041.
179. Knol J., Boehm G., Lidestri L., Negretti F., Jelinek J., Agosti M., Stahl B., Marini A., Mosca F. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr. 2005, 94(Suppl. 449):31-33.
180. Knol J., Scholtens P., Kafka C., Steenbakkers J., Groß S., Helm K., Klarczyk M., Schopfer H., Bockler H.M., Wells J. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast fed infants. J. Pediatr. Gastroenterol. Nutr. 2005, 40:36-42.
181. Koebnick C., Wagner I., Leitzmann P., Stern U., Zunft H.J. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can. J. Gastroenterol. 2003, 17:655-659.
182. Koletzko B., Aggett P.J., Bindels J.G., Bung P., Ferré P., Gil A., Lentze M.J., Roberfroid M., Strobel S. Growth, development and differentiation: a functional food science approach. Br. J. Nutr. 1998, 80(Suppl. 1):5-45.
183. Kuehni C.E., Davis A., Brooke A.M., Silverman M. Are all wheezing disorders in very young (preschool) children increasing in prevalence?. Lancet 2001, 357:1821-1825.
184. Kuisma J., Mentula S., Jarvinen H., Kahri A., Saxelin M., Farkkila M. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment. Pharmacol. Ther. 2003, 17(4):509-515.
185. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Kuitunen M. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119:192-198.
186. Kullen M.J., Bettler J. The delivery of probiotics and prebiotics to infants. Curr. Pharm. Des. 2005, 11:55-74.
187. Kunz C., Rodriguez-Palmero M., Koletzko B., Jensen R. Nutritional and biochemical properties of human milk. Clin. Perinatol. 1999, 26(Suppl. 2):307-333.
188. Kurugol Z., Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 2005, 94:44-47.
189. Kwon J., Farrel R. Probiotics and inflammatory bowel disease. BioDrug 2003, 17:179-186.
190. Laake K.O., Line P.D., Aabakken L., Lotveit T., Bakka A., Eide J., Roseth A., Grzyb K., Bjorneklett A., Vatn M.H. Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scand. J. Gastroenterol. 2003, 38:409-414.
191. Laiho K., Lampi A.M., Hamalainen M., et al. Breast milk fatty acids, eicosanoids and cytokines in mothers with and without allergic disease. Pediatr. Res. 2003, 53:642-647.
192. Lane M.C., Lockatell V., Monterosso G., Lamphier D., Weinert J., Hebel J.R., Johnson D.E., Mobley H.L. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 2005, 73(Suppl. 11):7644-7656.
193. Langlands S.J., Hopkins M.J., Coleman N., Cummings J.H. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004, 53:1610-1616.
194. Lee A. Neglected niches: "The microbial etiology of the gastrointestinal tract". Advances in Microbial Ecology 1984, 115-162. Plenum Press, New York. K.C. Marshal (Ed.).
195. Lin H.C., Su B.H., Chen A.C., Lin T.W., Tsai C.H., Yeh T.F., Oh W. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005, 115(1):1-4.
196. Lin P.W., Nasr T.R., Stoll B.J. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin. Perinatol. 2008, 32:70-82.
197. Linsalata M., Russo F., Berloco P., Caruso M.L., Matteo G.D., Cifone M.G., Simone C.D., Ierardi E., Di Leo A. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004, 9:165-172.
198. Lodinova-Zadnikova R., Sonnenborn U. Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol. Neonate 1997, 71:224-232.
199. Lodinova-Zadnikova R., Tlaskalova-Hogenova H., Sonnenborn U. Local and serum antibody response in full-term and premature infants after artificial colonization of the intestine with E. coli strain Nissle 1917 (Mutaflor). Pediatr. Allergy Immunol. 1992, 3:43-48.
200. Lohner S., Küllenberg D., Antes G., Decsi T., Meerpohl J.J. Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis. Nutr. Rev. 2014, 72(8):523-531.
201. Loo E.X., Llanora G.V., Lu Q., Aw M.M., Lee B.W., Shek L.P. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int. Arch. Allergy Immunol. 2014, 163(1):25-28.
202. Lundequist B., Nord C.E., Winberg J. The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Acta Paediatr. Scand. 1985, 74:45-51.
203. Luoto R., Kalliomaki M., Laitinen K., Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int. J. Obes. (Lond) 2010, 34:1531-1537.
204. Luoto R., Collado M.C., Salminen S., Isolauri E. Reshaping the gut microbiota at an early age: functional impact on obesity risk?. Ann. Nutr. Metab. 2013, 63(Suppl. 2):17-26.
205. Luoto R., Ruuskanen O., Waris M., Kalliomäki M., Salminen S., Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2014, 133(2):405-413.
206. MacDonald T.T., Gordon J.N. Bacterial regulation of intestinal immune responses. Gastroenterol. Clin. North Am. 2005, 34:401.
207. Mack D.R. Probiotics in inflammatory bowel diseases and associated conditions. Nutrients 2011, 3:245-264.
208. Mack D.R., Michail S., Wei S., McDougall L., Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276(4 Pt 1):941-950.
209. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121(3):580-591.
210. Magne F., Suau A., Pochart P., Desjeux J.F. Fecal microbial community in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2005, 41:386-392.
211. Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997, 99:179-185.
212. Majamaa H., Isolauri E., Saxelin M., Vesijar I.T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995, 20:333-338.
213. Malfertheiner P., Megraud F., O'Morain C.A., Atherton J., Axon A.T., Bazzoli F. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012, 61:646-664.
214. Mandar R., Mikelsaar M. Transmission of mother's microflora to the newborn at birth. Biol. Neonate 1996, 69:30-35.
215. Marin M.L., Tejada-Simon M.V., Lee J.H., Murtha J., Ustunol Z., Pestka J.J. Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J. Food Prot. 1998, 61(7):859-864.
216. Marrs C.F., Zhang L., Foxman B. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?. FEMS Microbiol. Lett. 2005, 252(Suppl. 2):183-190.
217. Marshall J.K., Thabane M., Borgaonkar M.R., James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin. Gastroenterol. Hepatol. 2007, 5:457-460.
218. Marteau P., Pochart P., Flourié B., Pellier P., Santos L., Desjeux J.F., Rambaud J.C. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am. J. Clin. Nutr. 1990, 52:685-688.
219. Marteau P., de Vrese M., Cellier C.J., Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 2001, 73(Suppl. 2):430-436.
220. Marteau P., Cuillerier E., Meance S., Gerhardt M.F., Myara A., Bouvier M., Bouley C., Tondu F. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment. Pharmacol. Ther. 2002, 16:587-593.
221. Marteau P., Seksik P., Shanahan F. Manipulation of the bacterial flora in inflammatory bowel disease. Best Pract. Res. Clin. Gastroenterol. 2003, 17:47-61.
222. Martin C.R., Walker W.A. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin. Perinatol. 2008, 32:127-137.
223. Meijer B.J., Dieleman L.A. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J. Clin. Gastroenterol. 2011, 45(Suppl.):S139-S144.
224. Ménard O., Butel M.J., Gaboriau-Routhiau V., Waligora-Dupriet A.J. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl. Environ. Microbiol. 2008, 74(3):660-666.
225. Meucci, S., Cannella, C., 2003. Yogurt e latti fermentati: probiotici e Prebiotici. Atti 2nd Probiotics & Prebiotics New Foods, pp. 36-44.
226. Millar M., Wilks M., Costeloe K. Probiotics for preterm infants?. Arch. Dis. Child. Fetal Neonatal Ed. 2003, 88:354-358.
227. Mirelman D. Microbial Lectins and Agglutinins: Properties and Biological Activities 1986, Wiley, New York.
228. Moayyedi P., Ford A.C., Talley N.J., Cremonini F., Foxx-Orenstein A.E., Brandt L.J. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010, 59:325-332.
229. Mollenbrink M., Bruckschen E. Treatment of chronic constipation with physiological E. coli bacteria. Results of a clinical trial on the efficacy and compatibility of microbiological therapy with the E. coli strain Nissle 1917 (Mutaflor R). Med. Klin. 1994, 89:587-593.
230. Moore N., Chao C., Yang L., Storm H., Oliva-Hemker M., Saavedra J.M. Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. Br. J. Nutr. 2003, 90:581-587.
231. Moreau M.C. Influence of resident intestinal microflora on the development and functions of the GALT. Microb. Ecol. Health Dis. 2001, 13:65-86.
232. Moretti A., Papi C., Koch M., Capurso L. Impiego dei probiotici in gastroenterologia: quali evidenze?. Argom. Gastroenterol. Clin. 2006, 19:31-39.
233. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., Mizumachi K., Kurisaki J. Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion. Microbiol. Immunol. 2002, 46(4):293-297.
234. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 2002, 34:291-295.
235. Moro G., Stahl B., Fanaro S., Jelinek J., Boehm G., Coppa G.V. Dietary prebiotic oligosaccharides are detectable in faeces of formula fed infants. Acta Paediatr. Suppl. 2005, 94:27-30.
236. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 2006, 91:814-819.
237. Mugambi M.N., Musekiwa A., Lombard M., Young T., Blaauw R. Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review. Nutr. J. 2012, 11:58.
238. Mugambi M.N., Musekiwa A., Lombard M., Young T., Blaauw R. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr. J. 2012, 11:81.
239. Murch S.H. Toll of allergy reduced by probiotics. Lancet 2001, 357:1057-1059.
240. Nader N., Youssef M.D. Childhood and adolescent constipation: review and advances in management. Curr. Treat. Options Gastroenterol. 2007, 10:401-411.
241. Neu J. Perinatal and neonatal manipulation of the intestinal microbiome: a note of caution. Nutr. Rev. 2007, 65:282-285.
242. Neut C., Bezirtzoglou E., Romond C., Beerens H., Delcroix M., Noel A.M. Bacterial colonization of the large intestine in newborns delivered by cesarean section. Zentralbl. Bakteriol. Mikrobiol. Hyg. B 1987, 266:330-337.
243. Newburg D.S., Neubauer S.H. Carbohydrates in milk. Handbook of Milk Composition 1995, 34-123. Academic Press, San Diego. R.G. Jensen (Ed.).
244. Newman D. The treatment of cystitis by intravesical injection of lactic bacillus cultures. Lancet 1915, 14:330-332.
245. O'Hara A.M., Shanahan F. Gut microbiota: mining for therapeutic potential. Clin. Gastroenterol. Hepatol. 2007, 5:274-284.
246. Oddy W.H. The impact of breast milk on infant and child health. Breastfeed. Rev. 2002, 10:5-18.
247. Oldaeus G., Anjou K., Bjorkstén B., Moran J.R., Kjellman N.I. Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch. Dis. Child. 1997, 77:4-10.
248. Oozeer R., van Limpt K., Ludwig T., Ben Amor K., Martin R., Wind R.D., Boehm G., Knol J. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am. J. Clin. Nutr. 2013, 98(2):561S-571S.
249. Orrhage K., Nord C.E. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr. Suppl. 1999, 88:47-57.
250. Osborn D.A., Sinn J.K. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst. Rev. 2007, 4:CD006475.
251. Ouwehand A., Isolauri E., Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur. J. Nutr. 2002, 41(Suppl. 1):132-137.
252. Ouwehand A.C., Lagstrom H., Suomalainen T., Salminen S. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann. Nutr. Metab. 2002, 46:159-162.
253. Ouwehand A.C., Derrien M., de Vos W., Tiihonen K., Rautonen N. Prebiotics and other microbial substrates for gut functionality. Curr. Opin. Biotechnol. 2005, 16(Suppl. 2):212-217.
254. Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin. Exp. Immunol. 2010, 160:295-304.
255. Palmer C., Bik E.M., Digiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol. 2007, 5(7):e177.
256. Panigrahi P., Gupta S., Gewolb I.H., Morris J.G. Occurrence of necrotizing enterocolitis may be dependent on patterns of bacterial adherence and intestinal colonization: studies in Caco-2 tissue culture and weanling rabbit models. Pediatr. Res. 1994, 36:115-121.
257. Parham N.J., Pollard S.J., Desvaux M., Scott-Tucker A., Liu C., Fivian A., Henderson I.R. Distribution of the serine protease autotransporters of the Enterobacteriaceae among extraintestinal clinical isolates of Escherichia coli. J. Clin. Microbiol. 2005, 43(Suppl. 8):4076-4082.
258. Parracho H., McCartney A.L., Gibson G.R. Probiotics and prebiotics in infant nutrition. Proc. Nutr. Soc. 2007, 66:405-411.
259. Pashapour N., Iou S.G. Evaluation of yogurt effect on acute diarrhea in 6-24-month-old hospitalized infants. Turk. J. Pediatr. 2006, 48:115-118.
260. Pedersen A., Sandström B., Van Amelsvoort J.M. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br. J. Nutr. 1997, 78(2):215-222.
261. Pedone C.A., Arnaud C.C., Postaire E.R., Bouley C.F., Reinert P. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract. 2000, 54:568-571.
262. Pelucchi C., Chatenoud L., Turati F., Galeone C., Moja L., Bach J.F. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012, 23:402-414.
263. Penders J., Vink C., Driessen C., London N., Thijs C., Stobberingh E.E. Quantification of Bifidobacterium spp. Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol. Lett. 2005, 243:141-147.
264. Penders J., This C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., Stobberingh E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
265. Peng G.C., Hsu C.H. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr. Allergy Immunol. 2005, 16:433-438.
266. Petitprez K., Khalife J., Cetre C., Fontaine J., Lafitte S., Capron A., Grzych J.M. Cytokine RNA expression in lymphoid organs associated with the expression of IgA response in rat. Scand. J. Immunol. 1999, 49:14-20.
267. Plummer S., Weaver M.S., Harris J.C., Dee P., Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhea. Int. Microbiol. 2004, 7:59-62.
268. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 2004, 114(1):131-136.
269. Posserud I., Stotzer P.O., Björnsson E.S., Abrahamsson H., Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56(6):802-808.
270. Premysl F. Probiotics and prebiotics - renaissance of a therapeutic principle. CEJMed 2007, 2(3):237-270.
271. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
272. Rahimi R., Nikfar S., Rahimi F., Elahi B., Derakhshani S., Vafaie M. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig. Dis. Sci. 2008, 53:2524-2531.
273. Rastall R.A. Bacteria in the gut: friends and foes and how to alter the balance. J. Nutr. 2004, 134:2022-2026.
274. Rastall R.A., Fuller R., Gaskins H.R., Gibson G.R. Colonic functional foods. Functional Foods 2000, 71-89. Woodhead Publishing Limited, Cambridge. G.R. Gibson, C.M. Williams (Eds.).
275. Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol. 2002, 109:119-121.
276. Rautava S., Arvilommi H., Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr. Res. 2006, 60:221-224.
277. Rechkemmer G., Rönnau K., von Engelhardt W. Fermentation of polysaccharides and absorption of short chain fatty acids in the mammalian hindgut. Comp. Biochem. Physiol. 1988, 90(Suppl. 4):563-568.
278. Reid G. Probiotic agents to protect the urogenital tract against infection. Am. J. Clin. Nutr. 2001, 73:437-443.
279. Reid G., Bruce A.W. Probiotics to prevent urinary tract infections: the rationale and evidence. World J. Urol. 2006, 24:28-32.
280. Reid G., Bruce A.W., Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol. Ther. 1995, 23:32-45.
281. Reid G., Hammond J.A., Bruce A.W. Effect of lactobacilli oral supplement on the vaginal microflora of antibiotic treated patients: randomized, placebo-controlled study. Nutraceut. Food 2003, 8:145-148.
282. Ribeiro J.H. Diarrheal disease in a developing nation. Am. J. Gastroenterol. 2000, 95(Suppl. 1):14-15.
283. Rinne M., Kirjavainen P., Salminen S., Isolauri E. Lactulose-any clinical benefits beyond constipation relief? A pilot study in infants with allergic symptoms. Bioscience Microflora 2003, 22:155-157.
284. Rinne M., Kalliomaki M., Arvilommi H., Salminen S., Isolauri E. Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/ enterococcus microbiota and humoral immune responses. J. Pediatr. 2005, 147:186-191.
285. Rinne M.M., Gueimonde M., Kalliomaki M., Hoppu U., Salminen S.J., Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol. Med. Microbiol. 2005, 43:59-65.
286. Rivero-Urgell M., Santamaria-Orleans A. Oligosaccharides: application in infant food. Early Hum. Dev. 2001, 65:43-52.
287. Roberfroid M.B. Prebiotics and probiotics: are they functional food?. Am. J. Clin. Nutr. 2000, 71:1682-1687.
288. Roberfroid M. Prebiotics: the concept revisited. J. Nutr. 2007, 137(3 Suppl. 2):830S-837S.
289. Roberfroid M. Prebiotics: the concept revisited. J. Nutr. 2007, 137:830-837.
290. Roberfroid M.B., Delzenne N.M. Dietary fructans. Annu. Rev. Nutr. 1998, 18:117-143.
291. Roller M., Rechkemmer G., Watzl B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J. Nutr. 2004, 134:153-156.
292. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J. Allergy Clin. Immunol. 2004, 113:395-400.
293. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Møller P.L., Pedersen P., Tvede M., Weyrehter H., Valerius N.H., Paerregaard A. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr. Infect. Dis. J. 2002, 21(5):411-416.
294. Rosenfeldt V., Michaelsen K.F., Jakobsen M., Larsen C.N., Møller P.L., Tvede M., Weyrehter H., Valerius N.H., Paerregaard A. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr. Infect. Dis. J. 2002, 21(5):417-419.
295. Rosenfeldt V., Benfeldt E., Nielsen S.D., Michaelsen K.F., Jeppesen D.L., Valerius N.H., Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 2003, 111(2):389-395.
296. Rosenfeldt V., Benfeldt E., Valerius N.H., Paerregaard A., Michaelsen K.F. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 2004, 145:612-616.
297. Rozee K.R., Cooper D., Lam K., Costerton J.W. Microbial flora of the mouse ileum mucosa layer and epithelial surface. Appl. Environ. Microbiol. 1982, 43:1451-1463.
298. Rycroft C.E., Fooks L.J., Gibson G.R. Methods for assessing the potential of prebiotics and probiotics. Curr. Opin. Clin. Nutr. Metab. Care 1999, 2:1-4.
299. Saavedra J.M. Clinical applications of probiotic agents. Am. J. Clin. Nutr. 2001, 73:1147-1151.
300. Saavedra J.M. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr. Clin. Pract. 2007, 22(3):351-365.
301. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., Yolken R.H. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994, 344:1046-1049.
302. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J. Clin. Gastroenterol. 2004, 38:104-106.
303. Saglani S., Payne D.N., Zhu J., Wang Z., Nicholson A.G., Bush A., Jeffery P.K. Early detection of airway wall remodelling and eosinophilic inflammation in preschool wheezers. Am. J. Respir. Crit. Care Med. 2007, 176:858-864.
304. Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand. J. Gastroenterol. Suppl. 1994, 202:7-20.
305. Saint-Marc T., Rossello-Prats L., Touraine J.L. Efficacité de Saccharomyces boulardii dans le traitment des diarrhées du SIDA. Ann. Méd. Interne (Paris) 1991, 142:64-65.
306. Saint-Marc T., Blehaut H., Musial Ch., Touraine J.L. Diarrhoenim zusammenhang mit AIDS (doppelblind studie mit Saccharomyces Boulardii. Sem. Hospitaux (Paris) 1995, 71:735-741.
307. Sakata H., Yoshioka H., Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur. J. Pediatr. 1985, 144:186-190.
308. Salminen S., Bouley C., Boutron-Ruault M.C., Cummings J.H., Franck A., Gibson G.R., Isolauri E., Moreau M.C., Roberfroid M., Rowland I. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 1998, 80:147-171.
309. Salonen A., De Vos W.M., Palva A. Gastro-intestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010, 156:3205-3215.
310. Salvini F. Le sostanze funzionali nel latte materno e nella dieta del bambino. Doctor Pediatria 2003, 12:18-23.
311. Samuli R. Potential uses of probiotics in the neonate. Semin. Fetal Neonatal Med. 2007, 12:45-53.
312. Sanderson I.R., Walker W.A. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 1993, 104:622-639.
313. Sandine W.E. Roles of bifidobacteria and lactobacilli in human health. Contemp. Nutr. 1990, 15:1.
314. Sanz Y., Rastmanesh R., Agostoni C. Understanding the role of gut microbes and probiotics in obesity: how far are we?. Pharmacol. Res. 2013, 69:144-155.
315. Saran S., Gopalan S., Krishna T.P. Use of fermented foods to combat stunting and failure to thrive. Nutrition 2002, 18:393-396.
316. Sarker S.A., Sultana S., Fuchs G.J., Alam N.H., Azim T., Brüssow H., Hammarström L. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 2005, 116(2):221-228.
317. Sartor R.B. Targeting enteric bacteria in treatment of inflammatory bowel diseases: "Why, how and when". Curr. Opin. Gastroenterol. 2003, 19:358-365.
318. Sartor R.B. Probiotic therapy of intestinal inflammation and infections. Curr. Opin. Gastroenterol. 2005, 21:44-50.
319. Savino F., Cresi F., Maccario S., Cavallo F., Dalmasso P., Fanaro S., Oggero R., Vigi V., Silvestro L. "Minor" feeding problems during the first months of life: effect of a partially hydrolyzed milk formula containing fructo- and galacto-oligosaccharides. Acta Paediatr. 2003, 92(Suppl. 441):86-90.
320. Savino F., Maccario S., Castangno E., Cresi F., Cavallo F., Dalmasso P., Fanaro S., Oggero R., Silvestro L. Advances in the management of digestive problems during the first months of life. Acta Paediatr. 2005, 94(Suppl. 449):120-124.
321. Sazawal S., Dhingra U., Sarkar A. Efficacy of milk fortified with a probiotic Bifidobacterium lactis (DR-10TM) and prebiotic galacto- oligosaccharides in prevention of morbidity and on nutritional status. Asia Pac. J. Clin. Nutr. 2004, 13(Suppl.):28.
322. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 2006, 6:374-382.
323. Schmelzle H., Wirth S., Skopnik H., Radke M., Knol J., Bockler H.M., Bronstrup A., Wells J., Fusch C. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J. Pediatr. Gastroenterol. Nutr. 2003, 36:343-351.
324. Scholtens P., Alles M., Bindels J., van der Linde E., Toolbom J.J.M., Knol J. Bifidogenic effect of solid weaning foods with added prebiotic oligosaccharides: a randomized controlled clinical trial. J. Pediatr. Gastroenterol. Nutr. 2006, 42:553-559.
325. Scholtens P.A., Alles M.S., Bindels J.G., van der Linde E.G., Tolboom J.J., Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J. Pediatr. Gastroenterol. Nutr. 2006, 42:553-559.
326. Schwiertz A., Gruhl B., Löbnitz M., Michel P., Radke M., Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr. Res. 2003, 54:393-399.
327. Seung J.L., Yoon H.S., Su J.C., Jung W.L. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr. Nephrol. 2007, 22:1315-1320.
328. Shanahan F. The host-microbe interface within the gut. Best Pract. Res. Clin. Gastroenterol. 2002, 16:915-931.
329. Shen J., Obin M.S., Zhao L. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 2013, 34:39-58.
330. Snyder J.A., Haugen B.J., Lockatell C.V., Maroncle N., Hagan E.C., Johnson D.E., Welch R.A., Mobley H.L. Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect. Immun. 2005, 73(Suppl. 11):7588-7596.
331. Snydman D.R. The safety of probiotics. Clin. Infect. Dis. 2008, 46(Suppl. 2):S104-S111.
332. Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., Neal K.R. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47(6):804-811.
333. Stahl B., Thurl S., Zeng J., Karas M., Hillenkamp F., Steup M., Sawatzki G. Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 1994, 223(2):218-226.
334. Stark P.L., Lee A. The bacterial colonization of the large bowel of preterm low birth weight neonates. J. Hyg. (Lond) 1982, 89:59-67.
335. Stark P.L., Lee A. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J. Med. Microbiol. 1982, 15:189-203.
336. Stratiki Z., Costalos C., Sevastiadou S., Kastanidou O., Skouroliakou M., Giakoumatou A., Petrohilou V. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum. Dev. 2007, 83(9):575-579.
337. Sudarmo S.M., Ranuh R.G., Rochim A., Soeparto P. Management of infant diarrhea with high-lactose probiotic-containing formula. Southeast Asian J. Trop. Med. Public Health 2003, 34:845-848.
338. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 1997, 159:1739-1745.
339. Swidsinski M.K., Ortner M. Alteration of bacterial concentration in colonic biopsies from patients with irritable bowel syndrome (IBS). Gastroenterology 1999, 115:A-1.
340. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., Weber J., Hoffmann U., Schreiber S., Dietel M., Lochs H. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44-54.
341. Sykora J., Valeekova K.K.V., Amlerova J.J.A. Supplements of a one week triple drug therapy with special probiotic Lactobacillus casei immunitass (strain DN 114000) and Streptococcus thermophilus and Lactobacillus bulgaricus in the eradication of H. pylori-colonized children: a prospective randomised trial. J. Pediatr. Gastroenterol. Nutr. 2004, 39(Suppl. 1):400.
342. Szajewska H., Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 2001, 33(Suppl. 2):17-25.
343. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 2001, 138:361-365.
344. Szajewska H., Ruszczynski M., Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 2006, 149:367-373.
345. Szajewska H., Wanke M., Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment. Pharmacol. Ther. 2011, 34(9):1079-1087.
346. Szilagyi A. Prebiotics or probiotics for lactose intolerance: a question of adaptation. Am. J. Clin. Nutr. 1999, 70:105-106.
347. Szymanski H., Pejcz J., Jawien M., Chmielarczyk A., Strus M., Heczko P.B. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains: a randomized, double-blind, placebo-controlled trial. Aliment. Pharmacol. Ther. 2006, 23:247-253.
348. Tabbers M.M., Boluyt N., Berger M.Y., Benninga M.A. Nonpharmacologic treatments for childhood constipation: systematic review. Pediatrics 2011, 128(4):753-761.
349. Takeda K., Suzuki T., Shimada S.I., Shida K., Nanno M., Okumura K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin. Exp. Immunol. 2006, 146(1):109-115.
350. Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: the incidence and prognosis of postinfectious irritable bowel syndrome. Aliment. Pharmacol. Ther. 2007, 26:535-544.
351. Thurl S., Henker J., Siegel M., Tovar K., Sawatzki G. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconj. J. 1997, 14:795-799.
352. Tissier, H., Callè, G., Naud, C., 1900. Recherches sur la flore intestinale des nourissons (ètat normal et pathologique).
353. Troelsen J.T. Adult-type hypolactasia and regulation of lactase expression. Biochim. Biophys. Acta 2005, 1723:19-32.
354. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
355. Underwood M.A., Gilbert W.M., Sherman M.P. Amniotic fluid: not just fetal urine anymore. J. Perinatol. 2005, 25:341-348.
356. Usein C.R., Damian M., Tatu-Chitoiu D., Capusa C., Fagaras R., Mircescu G. Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections. Roum. Arch. Microbiol. Immunol. 2003, 62(Suppl. 3-4):137-154.
357. van den Heuvel E.G., Muys T., van Dokkum W., Schaafsma G. Oligofructose stimulates calcium absorption in adolescents. Am. J. Clin. Nutr. 1999, 69(3):544-548.
358. van Hoffen E., Ruiter B., Faber J., M'Rabet L., Knol E.F., Stahl B., Arslanoglu S., Moro G., Boehm G., Garssen J. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at risk for allergy. Allergy 2009, 64:484-487.
359. Van Loo J., Cummings J., Delzenne N., Englyst H., Franck A., Hopkins M., Kok N., Macfarlane G., Newton D., Quigley M., Roberfroid M., van Vliet T., van den Heuvel E. Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br. J. Nutr. 1999, 81(Suppl. 2):121-132.
360. Van Niel C.W., Feudtner C., Garrison M.M., Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109:678-684.
361. van Vliet, T., 1997. A double placebo controlled, parallel trial on the effect of oligofructose intake on serum lipids in male volunteers. Report TNO 97, 874.
362. Vandenplas Y. Clinical overview the changing pattern of clinical aspects of allergic diseases. Allergic Diseases and the Environment. Nestlé Nutrition Workshop Series 2004, 1-25. Nestec Ltd Vevey/S. Karger AG, Basel (Switzerland). E. Isolauri, W.A. Walker (Eds.).
363. Vanderhoof J.A., Young R.J. Probiotics in pediatrics. Pediatrics 2002, 109:956-958.
364. Veereman-Wauters G., Staelens S., Van de Broek H., Plaskie K., Wesling F., Roger L.C., McCartney A.L., Assam P. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J. Pediatr. Gastroenterol. Nutr. 2011, 52(6):763-771.
365. Venderhoof J.A., Whitney D.B., Antonson D.L., Hanner T.L., Lupo J.V., Young R.J. Lactobacillus GG in the prevention of antibiotic associated diarrhea in children. J. Pediatr. 1999, 135:564-568.
366. Viljanen M., Kuitunen M., Haahtela T., Juntunen-Backman K., Korpela R., Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol. 2005, 16(1):65-71.
367. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005, 60(4):494-500.
368. von Berg A. The concept of hypoallergenicity for atopy prevention. Nestle Nutr. Workshop Ser. Pediatr. Program. 2007, 59(49-57):57-62.
369. von Berg A., Koletzko S., Grubl A., Filipiak-Pittroff B., Wichmann H.E., Bauer C.P., Reinhardt D., Berdel D. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J. Allergy Clin. Immunol. 2003, 111:533-540. German Infant Nutritional Intervention Study Group.
370. von Berg A., Koletzko S., Filipiak-Pittroff B., Laubereau B., Grubl A., Wichmann H.E., Bauer C.P., Reinhardt D., Berdel D. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J. Allergy Clin. Immunol. 2007, 119:718-725. German Infant Nutritional Intervention Study Group.
371. Waligora-Dupriet A.J., Butel M.J. Microbiota and allergy: from dysbiosis to probiotics. Allergic Diseases-Highlights in the Clinic, Mechanisms and Treatment 2012, 413-434. Intech, Rijeka. C. Pereira (Ed.).
372. Waligora-Dupriet A.J., Campeotto F., Nicolis I., Bonet A., Soulaines P., Dupont C., Butel M.J. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int. J. Food Microbiol. 2007, 113:108-113.
373. Walker W.A. Role of nutrients and bacterial colonization in the development of intestinal host defense. J. Pediatr. Gastroenterol. Nutr. 2000, 30(Suppl. 2):2-7.
374. Walker W.A. Development of the intestinal mucosal barrier. J. Pediatr. Gastroenterol. Nutr. 2002, 34:33-39.
375. Walker W.A. Mechanisms of action of probiotics. Clin. Infect. Dis. 2008, 46(Suppl. 2):S87-S91. discussion S144-51.
376. Walker W.A. Initial intestinal colonization in the human infant and immune homeostasis. Ann. Nutr. Metab. 2013, 63(Suppl. 2):8-15.
377. Walker W.A., Goulet O., Morelli L., Antoine J.M. Progress in the science of probiotics: from cellular microbiology and applied immunology to clinical nutrition. Eur. J. Nutr. 2006, 45(Suppl. 1):1-18.
378. Wang K.Y., Li S.N., Liu C.S., Perng D.S., Su Y.C., Wu D.C., Jan C.M., Lai C.H., Wang T.N., Wang W.M. Effects of ingesting Lactobacillus and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 2004, 80(3):737-741.
379. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
380. Wenig M., Walker W.A., Sanderson I.R. Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr. Res. 2007, 62:542-546.
381. Weston S., Halbert A., Richmond P., Prescott S.L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child. 2005, 90:892-897.
382. Wullt M., Hagslatt M.L.J., Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand. J. Infect. Dis. 2003, 35:365-367.
383. Yahiro M., Nishikawa I., Murakami Y., Yoshida H., Ahiko K. Studies on application of galactosyl lactose for infant formula. II. Changes of fecal characteristics on infant fed galactosyl lactose. Reports of Research Laboratory, Snow Brand Milk Products 1992, 78:27-32.
384. Yap K.W., Mohamed S., Yazid A.M., Maznah I., Meyer D.M. Dose-response effects of inulin on fecal short-chain fatty acids content and mineral absorption of formula fed infants. Nutr. Food Sci. 2005, 35:208-219.
385. Yoshioka H., Iseki K., Fujita K. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 1983, 72:317-321.
386. Zhang L., Li N., Neu J. Probiotics for preterm infants. NeoReviews 2005, 6:227-232.
387. Ziegler E.E., Jeter J.M., Drulis J.M. Formula with reduced content of improved, partially hydrolyzed protein and probiotics: infant growth and health. Monatsschr. Kinderheilkd. 2003, 1:565-571.
388. Ziegler E., Vanderhoof J.A., Petschow B., Mitmesser S.H., Stolz S.I., Harris C.L., Berseth C.L. Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 2007, 44:359-364.
389. Zuppa A.A., Savarese I., Scorrano A., Calabrese V., D'Andrea V., Fracchiolla A., Cota F., Sindico P. Prebiotics and probiotics in infant nutrition. Pediatr. Med. Chir. 2007, 29:69-83.